With the studies she continues at the Izmir Biomedicine and Genome Center, her project aims to obtain a new generation antibody drug that has dual specificity and can be used in the treatment of lung cancer. This can enable the immune system to start a bilateral war on cancer. Her research on developing an original drug may provide a new treatment strategy for lung cancer, which still causes thousands of deaths.